Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to evaluate the efficacy and safety of recombinant anti-tumor and anti-virus protein for injection in treating patients with metastatic colorectal cancer after failure of second-line and more than second-line treatment.
Epistemonikos ID: c1667d3e8ccb1a8e0aeb50802e4a6fac48fbcc2a
First added on: Mar 23, 2020